AI Tokens
Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

This company has been moved to the archive! The financial data has not been updated since May 6, 2024.

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin

Microsoft Excel

Two-Component Disaggregation of ROE

Shockwave Medical Inc., decomposition of ROE

Microsoft Excel
ROE = ROA × Financial Leverage
Dec 31, 2023 22.03% = 9.40% × 2.34
Dec 31, 2022 42.24% = 33.43% × 1.26
Dec 31, 2021 -3.78% = -2.64% × 1.43
Dec 31, 2020 -29.11% = -24.15% × 1.21
Dec 31, 2019 -26.53% = -22.04% × 1.20

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


The analysis of the two-component DuPont disaggregation reveals a significant transformation in financial performance from 2019 to 2023, characterized by a transition from operational losses to profitability and a notable shift in the capital structure.

Return on Assets (ROA)
A volatile trajectory is observed in asset efficiency. The period began with substantial negative returns in 2019 (-22.04%) and 2020 (-24.15%), followed by a sharp recovery in 2021. Asset productivity peaked in 2022 at 33.43% before experiencing a contraction to 9.40% in 2023.
Financial Leverage
The capital structure remained relatively stable and conservative from 2019 through 2022, with the leverage ratio fluctuating within a narrow range between 1.20 and 1.43. A significant increase occurred in 2023, where the ratio rose to 2.34, indicating a marked increase in the use of debt or liabilities to finance assets.
Return on Equity (ROE)
ROE closely tracked the performance of ROA during the initial years, remaining negative through 2021. A peak ROE of 42.24% was achieved in 2022, driven predominantly by the surge in asset efficiency. In 2023, although ROA declined significantly, the ROE was maintained at a positive 22.03%, reflecting the magnifying effect of the increased financial leverage on the remaining asset returns.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Three-Component Disaggregation of ROE

Shockwave Medical Inc., decomposition of ROE

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Dec 31, 2023 22.03% = 20.17% × 0.47 × 2.34
Dec 31, 2022 42.24% = 44.10% × 0.76 × 1.26
Dec 31, 2021 -3.78% = -3.85% × 0.69 × 1.43
Dec 31, 2020 -29.11% = -96.92% × 0.25 × 1.21
Dec 31, 2019 -26.53% = -119.06% × 0.19 × 1.20

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


The Return on Equity (ROE) demonstrates a significant turnaround over the observed five-year period, transitioning from substantial negative returns to positive profitability. The progression reveals a shift in the primary drivers of equity returns, moving from a focus on operational recovery and efficiency to a heightened reliance on financial leverage in the final year.

Net Profit Margin
A dramatic improvement in profitability is observed, with the margin ascending from -119.06% in 2019 to a peak of 44.10% in 2022. While there was a contraction to 20.17% in 2023, the trend indicates a successful transition from a high-loss phase to a stable profit-generating state.
Asset Turnover
Asset utilization efficiency showed a consistent upward trend from 2019 (0.19) through 2022 (0.76). However, a sharp decline to 0.47 occurred in 2023, indicating that the entity generated less revenue per unit of asset in the most recent period compared to previous years.
Financial Leverage
The leverage ratio remained relatively stable between 1.20 and 1.43 from 2019 to 2022. A significant spike is noted in 2023, where the ratio increased to 2.34, signaling a substantial increase in the proportion of debt relative to equity.
Return on Equity (ROE)
ROE followed the trajectory of the net profit margin, moving from -26.53% in 2019 to a high of 42.24% in 2022. In 2023, ROE declined to 22.03%. Analysis of the components suggests that while the decline was driven by lower profit margins and lower asset turnover, the impact was partially offset by the increase in financial leverage, which amplified the remaining returns to shareholders.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Five-Component Disaggregation of ROE

Shockwave Medical Inc., decomposition of ROE

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Dec 31, 2023 22.03% = 0.85 × 0.96 × 24.81% × 0.47 × 2.34
Dec 31, 2022 42.24% = 1.79 × 0.98 × 25.06% × 0.76 × 1.26
Dec 31, 2021 -3.78% = — × — × -3.26% × 0.69 × 1.43
Dec 31, 2020 -29.11% = — × — × -95.01% × 0.25 × 1.21
Dec 31, 2019 -26.53% = — × — × -116.72% × 0.19 × 1.20

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


The Return on Equity (ROE) exhibits a significant transition from substantial negative values in 2019 and 2020 to a peak of 42.24% in 2022, before moderating to 22.03% in 2023. This trajectory indicates a fundamental shift in financial performance and capital structure over the observed five-year period.

Operating Profitability
The EBIT margin served as the primary driver for the recovery and subsequent growth in ROE. A severe operating loss of -116.72% in 2019 improved consistently, crossing into positive territory by 2022 at 25.06% and remaining stable at 24.81% in 2023. This trend reflects a successful transition from a high-burn growth phase to operational profitability.
Asset Efficiency
Asset turnover demonstrated a strong upward trend from 0.19 in 2019 to a peak of 0.76 in 2022, signaling an increase in the efficiency of asset utilization to generate sales. However, a notable contraction to 0.47 occurred in 2023, suggesting a decrease in asset productivity during the final year of the period.
Financial Leverage
Financial leverage remained relatively stable, fluctuating between 1.20 and 1.43 from 2019 to 2022. A sharp increase to 2.34 was recorded in 2023, indicating a significant shift in the capital structure toward higher leverage, which acted as a multiplier for the ROE despite declines in asset turnover and the tax burden.
Tax and Interest Burdens
The interest burden remained near unity, moving from 0.98 in 2022 to 0.96 in 2023, suggesting that interest expenses have had a negligible impact on the conversion of operating profit to net income. The tax burden showed higher volatility, peaking at 1.79 in 2022—indicating tax benefits that amplified net income—before declining to 0.85 in 2023, which contributed to the reduction in overall ROE.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Two-Component Disaggregation of ROA

Shockwave Medical Inc., decomposition of ROA

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Dec 31, 2023 9.40% = 20.17% × 0.47
Dec 31, 2022 33.43% = 44.10% × 0.76
Dec 31, 2021 -2.64% = -3.85% × 0.69
Dec 31, 2020 -24.15% = -96.92% × 0.25
Dec 31, 2019 -22.04% = -119.06% × 0.19

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


The Return on Assets (ROA) trajectory demonstrates a significant transition from substantial operational losses to profitability, peaking in 2022 before experiencing a contraction in 2023. This evolution is driven by the combined effects of expanding net profit margins and fluctuating asset utilization efficiency.

Net Profit Margin
A sharp upward trend is observed from 2019 through 2022, moving from a deficit of -119.06% to a peak of 44.10%. This indicates a fundamental shift from a high-burn phase to strong operational profitability. However, a moderation occurred in 2023, with the margin declining to 20.17%, suggesting a potential increase in operating expenses or a shift in pricing dynamics.
Asset Turnover
Asset efficiency showed consistent improvement between 2019 and 2022, increasing from a ratio of 0.19 to 0.76. This growth reflects an enhanced ability to generate revenue relative to the asset base. This trend reversed in 2023, as the ratio fell to 0.47, indicating a decrease in the productivity of the assets employed in the business.
Return on Assets (ROA)
The ROA remained negative from 2019 to 2021, primarily suppressed by severe negative profit margins. The surge to 33.43% in 2022 represents the convergence of peak profitability and peak asset efficiency. The subsequent decline to 9.40% in 2023 is a direct result of the simultaneous deterioration in both net profit margins and asset turnover, indicating a general reduction in overall financial performance for the period.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Four-Component Disaggregation of ROA

Shockwave Medical Inc., decomposition of ROA

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Dec 31, 2023 9.40% = 0.85 × 0.96 × 24.81% × 0.47
Dec 31, 2022 33.43% = 1.79 × 0.98 × 25.06% × 0.76
Dec 31, 2021 -2.64% = — × — × -3.26% × 0.69
Dec 31, 2020 -24.15% = — × — × -95.01% × 0.25
Dec 31, 2019 -22.04% = — × — × -116.72% × 0.19

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


The return on assets (ROA) exhibited a volatile trajectory over the five-year period, transitioning from deep negative returns in 2019 and 2020 to a peak of 33.43% in 2022, before retreating to 9.40% in 2023. This progression reflects a fundamental shift in operational profitability coupled with significant fluctuations in tax impacts and asset utilization.

Operational Profitability (EBIT Margin)
A strong upward trend in the EBIT margin is observed, moving from -116.72% in 2019 to 24.81% in 2023. The most significant recovery occurred between 2021 and 2022, where the margin shifted from a near-breakeven -3.26% to 25.06%. This indicates a successful transition from an initial high-burn phase to a stable operating profit model.
Asset Utilization (Asset Turnover)
Asset turnover showed consistent improvement from 2019 (0.19) through 2022 (0.76), suggesting increasing efficiency in generating revenue from the asset base. However, a sharp decline to 0.47 in 2023 indicates a reduction in asset productivity or a significant expansion of the balance sheet that has not yet yielded proportional revenue growth.
Financial and Tax Burdens
The interest burden remained stable and near parity (0.98 in 2022 and 0.96 in 2023), indicating that interest expenses have a negligible impact on the net return. In contrast, the tax burden showed substantial variance; a ratio of 1.79 in 2022 suggests a tax benefit that inflated the ROA, while the decrease to 0.85 in 2023 indicates a tax expense that contributed to the reduction in final net returns.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Disaggregation of Net Profit Margin

Shockwave Medical Inc., decomposition of net profit margin ratio

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Dec 31, 2023 20.17% = 0.85 × 0.96 × 24.81%
Dec 31, 2022 44.10% = 1.79 × 0.98 × 25.06%
Dec 31, 2021 -3.85% = — × — × -3.26%
Dec 31, 2020 -96.92% = — × — × -95.01%
Dec 31, 2019 -119.06% = — × — × -116.72%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


The financial trajectory between 2019 and 2023 reveals a transition from substantial operating losses to a state of operational profitability and stability.

Operational Efficiency and EBIT Margin
A consistent upward trend in the EBIT margin is observed, moving from -116.72% in 2019 to a stabilized level of approximately 24.8% by 2023. The most significant inflection point occurred between 2021 and 2022, where the margin shifted from a near-break-even -3.26% to a positive 25.06%, indicating a successful scaling of operations and effective cost management.
Net Profit Margin Volatility
The net profit margin mirrored the operational recovery but exhibited higher volatility. After improving from -119.06% in 2019 to a peak of 44.10% in 2022, the margin contracted to 20.17% in 2023. This divergence from the relatively stable EBIT margin suggests that non-operating factors heavily influenced the bottom line during the final two years of the period.
Interest and Tax Burden Analysis
The interest burden remained consistently near 1.0, recorded at 0.98 in 2022 and 0.96 in 2023, signifying that interest expenses had a negligible impact on net profitability. Conversely, the tax burden experienced a sharp decline from 1.79 in 2022 to 0.85 in 2023. The tax burden ratio above 1.0 in 2022 indicates a tax benefit that significantly inflated the net profit margin relative to operating performance. The subsequent shift to 0.85 in 2023 reflects the realization of a standard tax liability, which serves as the primary driver for the contraction of the net profit margin despite the stability of the EBIT margin.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?